Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer. - Wikidata - wikimedia - TriplyDB

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

http://www.wikidata.org/entity/Q37823204

about

Skp2: a novel potential therapeutic target for prostate cancer Integrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3.CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.A critical role of toll-like receptor 2 (TLR2) and its' in vivo ligands in radio-resistance Preclinical Evaluation of Intraoperative Low-Energy Photon Radiotherapy Using Spherical Applicators in Locally Advanced Prostate Cancer A critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance.Pharmacotherapeutic management of locally advanced prostate cancer: current status.Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer Radiotherapy.Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides.Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP.

P2860

Q24625558-E4D3BF6C-F6A5-42A7-A4C8-FB5AA8D1686F Q26777128-8F2D7220-D93C-4013-A789-5BCCC18B21DB Q34791957-C625108F-F0E6-4361-801F-6143A457AA70 Q35116847-27E894AD-163B-4BEE-ADFF-E171F3B20CB5 Q35947809-47D7EC3F-26FC-4BFF-8EFF-91BF6708E5B5 Q36059956-92BF96B1-8B45-4784-9C1E-F486785612F5 Q36907139-AE6CCD5E-CCC0-4E4E-9976-A610829E9A01 Q37888666-FC1C1AE8-ABD2-4012-8157-FA258634F6C7 Q42383361-CCA973EE-31E0-4E88-909E-710825291A57 Q44262180-7E8C3747-113C-46E6-830C-3F4A1386976E Q55001540-DFF2C83C-FC72-4310-86D9-B49EA1C8AF55

P2860

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

http://www.wikidata.org/entity/Q37823204

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

@en

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

@nl

type

label

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

@en

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

@nl

prefLabel

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

@en

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

@nl

P1433

Q37823204-1B2DBAD4-7B78-4CF4-9FAE-F1E49CC72618

P1476

Q37823204-6274CA4C-05B9-48D3-AE1C-1F61294C0995

P2093

Q37823204-1C2279D5-AC74-4EA8-8543-079F36320CAC

Q37823204-8DEF8962-DE3E-4F99-AE7B-0D3935C80B51

Q37823204-F9A8E115-E379-49F1-B29B-5517C9932B08

Q37823204-FA822F30-E8BA-4204-942A-F988599DDC30

P2860

Q37823204-08BE97ED-7B48-4475-960B-E90B7360034F

Q37823204-1EB51F1B-A9BE-465A-8EA8-9CC101303857

Q37823204-2AF7B9E9-DD6C-414F-88A1-8703B55CAC4F

Q37823204-3D8CB7AE-943D-4875-A0C5-626FE7860139

Q37823204-44F90E11-B213-4F23-943F-2625209AE49F

Q37823204-45767D8C-AEF3-484D-9FF5-F8BC26786D43

Q37823204-4DF2B395-D19D-4C05-BE7E-C9BC84DE33A4

Q37823204-6CB02D13-3F52-4593-AA9F-FCC93D0662C1

Q37823204-71496E82-4F0E-485C-84DA-A1C834C823F6

Q37823204-82875F71-011E-46C6-AF25-D16E41F2A8B7

P304

Q37823204-791E0E3B-E6BA-452A-8CFB-4094481CCA96

P31

Q37823204-4a0d664f-fb46-4caf-a053-92551635a4b6

Q37823204-C71BCE8C-17DF-4448-A2CA-CE435C4F598D

P356

Q37823204-42DB6D0A-7F8D-4F5D-ACCF-CEC1099E5AEB

P407

Q37823204-3019465B-CCC6-481D-840A-3DE2AF0A9E07

P433

Q37823204-A0CBC3E5-5469-4523-B8A4-14F3EC3E586B

P478

Q37823204-FE963231-73BD-4AAD-AAA3-F8DD920695C9

P50

Q37823204-49C8DC57-1AC9-4F38-B81C-8AE7617D566D

Q37823204-5B9C677F-EA31-41A3-9F8E-62FA04BEEA6C

Q37823204-5BFB9239-853B-40B3-85DC-2C468D9FC25E

Q37823204-8AD0D408-4ABB-4230-8A0C-A7DFEC6FAC30

P577

Q37823204-27D5ECFE-3B7F-45E0-94FE-8ADDDC225D31

P698

Q37823204-E1B4963D-5C45-47B0-8108-DDFDFB8F1800

P921

Q37823204-476C0015-34D8-4E2F-9D34-9F5A40AA23E6

P356

NRCLINONC.2010.207

P1433

Nature Reviews Clinical Oncology

P1476

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

@en

P2093

Alexender R Zlotta

http://www.w3.org/2001/XMLSchema#string

Jayant S Goda

http://www.w3.org/2001/XMLSchema#string

John Thoms

http://www.w3.org/2001/XMLSchema#string

Neil E Fleshner

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.

Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.

Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.

Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

P304

107-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2010.207

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Stéphane Supiot

Robert G. Bristow

Theodorus H Van der Kwast

P577

2010-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21178999

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy